Immunosuppression Stocks List
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | F | ETFMG Treatments Testing and Advancements ETF | 3.72 | |
BBP | D | BioShares Biotechnology Products Fund | 1.93 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.86 | |
GURU | B | Global X Top Guru Holdings Index ETF | 1.39 | |
CNCR | C | Loncar Cancer Immunotherapy ETF | 1.07 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Mar 21 | IMCR | Immunocore files for mixed shelf, size not disclosed |
- Immunosuppression
Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.In general, deliberately induced immunosuppression is performed to prevent the body from rejecting an organ transplant. Additionally, it is used for treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, or Crohn's disease. This is typically done using medications, but may involve surgery (splenectomy), plasmapheresis, or radiation. A person who is undergoing immunosuppression, or whose immune system is weak for some other reasons (chemotherapy or HIV), is said to be immunocompromised.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles